Fred Hassan

Fred Hassan

Fortune : 14 M $ au 30/09/2026

80 ans
Health Technology
Consumer Services
Finance

Profil

Mr. Fred Hassan is a Chairman at Recursion Pharmaceuticals, Inc., an Independent Director at EyePoint, Inc., a Chairman at Saghmos Therapeutics, Inc., an Independent Director at Cocrystal Pharma, Inc., an Independent Director at BridgeBio Pharma, Inc., a Founder at Caret Pharma LLC, an Independent Director at Precigen, Inc., a Chairman at IM HealthScience LLC, an Advisor at Caerus Ventures LLC, a Chairman at Caret Group LLC, a Member at The Business Council and a Non-Executive Chairman at Physician's Seal LLC.
He is on the Board of Directors at EyePoint, Inc., Cocrystal Pharma, Inc., BridgeBio Pharma, Inc. and Precigen, Inc. Mr. Hassan was previously employed as an Independent Director by Prometheus Biosciences, Inc., an Independent Director by Amgen, Inc., a Managing Director by Warburg Pincus LLC, a Non-Executive Chairman by Bausch & Lomb, Inc., an Independent Director by Time Warner, Inc., a Chairman, President & Chief Executive Officer by Merck & Co., Inc., a Chairman & Chief Executive Officer by Schering-Plough Corp.
USA, a Chairman & Chief Executive Officer by Pharmacia Corp., a Non-Executive Chairman by Avon Products, Inc., a President & Chief Executive Officer by Pharmacia & Upjohn, Inc., a Director & Executive Vice President by American Home Products Corp., a President by Wyeth-Ayerst Laboratories, a President by International Federation of Pharmaceutical Manufacturers, a Chairman by Pharmaceutical Research & Manufacturers of America, a Principal by Sandoz Pharmaceuticals Corp., and a Chairman by Theramex HQ UK Ltd. He also served on the board at Valeant Pharmaceuticals International, Inc. and Electronic Data Systems Corp.
He received his undergraduate degree from Imperial College London and an MBA from Harvard Business School.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/03/2026 1 243 239 ( 0,42% ) 11 M $ 30/09/2026
22/06/2026 29 879 ( 0,02% ) 2 M $ 30/09/2026
19/05/2026 1 380 992 ( 7,17% ) 2 M $ 30/09/2026
21/04/2026 0 ( -.--% ) - $ 30/09/2026

Postes actifs de Fred Hassan

SociétésPosteDébut
PRECIGEN, INC. Directeur/Membre du Conseil 30/06/2016
BRIDGEBIO PHARMA, INC. Directeur/Membre du Conseil 17/08/2021
COCRYSTAL PHARMA, INC. Directeur/Membre du Conseil 20/04/2023
EYEPOINT, INC. Directeur/Membre du Conseil 03/09/2024
RECURSION PHARMACEUTICALS, INC. Président 31/10/2026
Fondateur 01/01/2017
Consultant / Advisor -
Président 03/10/2023
Président -
░░ ░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░ ░░░ ░░░░░░░░░ -

Anciens postes connus de Fred Hassan

SociétésPosteFin
░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░ ░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Fred Hassan

Formation de Fred Hassan

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

87

Relations au 1er degré

32

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées32

Health Technology

Health Technology

Consumer Non-Durables

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Technology Services

Consumer Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Commercial Services

Sandoz Pharmaceuticals Corp.

Health Technology

Wyeth-Ayerst Laboratories

Consumer Services

Finance

Health Technology

Health Services

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Fred Hassan